In initial studies, ER+ MCF-7 breast cancer cells were exposed to increasing concentrations of 4-hydroxytamoxifen (4-OHT); 4-OHT is an active metabolite of tamoxifen typically used for cell culture studies. The gene discussed is ESR1; the disease is breast carcinoma.